Structural alterations to chromosomes constitute a significant portion of the genetic damage produced by most mutagenic agents. The pioneering experiments of Muller (1) , in the case of ionizing radiations, and of Auerbach (2) , in the case of nitrogen mustards, showed that chromosome aberrations are, quantitatively, a significant class of mutational events for both physical and chemical mutagens. The is short-term tissue culture of peripheral leukocytes (3) . The procedure is technically simple, but it presents particular uncertainties and difficulties in interpreting the data. The experiments on human cells must be done in vitro, and the question arises as to whether the response is quantitatively and qualitatively the same as that in vivo. Second, the experiments are done on somatic cells, and the effect on the genetically important germ cells may be quite different. Third, even if the experiments are done on laboratory animals, where the germ eclls can be treated in vivo, the problem of differential cell stage sensitivity (4, 5) and interspecific variations in sensitivity (6) must be accounted for.
The present paper is addressed to those problems. The majority of the data are derived from experiments utilizing low-LET radiations as the mutagenic agent, although some data are presented from studies of chemical mutagens.
Comparisons of Aberration Production in Vivo and in Vitro
The most extensive quantitative data on the production of damage to 
Interspecific Comparisons
Before quantitative data derived in mutagenesis testing on laboratory animals can be used to make meaningful predictive statements concerning man, a "bridge" of information is needed between the two species. At present, chromosome aberration studies appear to offer the greatest possibility for establishing that "bridge", simply because there is already a great deal of information and because the current techniques lend themselves to rapid accumulation of large amounts of data.
We have recently finished an interspecific comparison of the radio-sensitivities of the peripheral leukocytes of several mammalian species (6) . In those experiments we irradiated freshly drawn blood, or the animal under study, with x-rays or y-rays at a high dose rate. The leukocytes were then cultured in various ways, and the resulting first mitotic divisions were analyzed for chromosome-type aberrations. The aberration types analyzed were asymmetrical interchanges (dicentrics), asymmetrical in- December 1973 terarm intrachanges (centric rings), and acentric fragments. Dose-response curves were made, and relative yields of dicentrics and acentric fragments presumed to be deletions were compared among species. Several facts were found. The yields of dicentrics increased exponentially with dose for all species (Fig. 1) . Although the yields of deletions were relatively constant among species, the yields of dicentrics were higher in the species with higher chromosome arm numbers. (19, 20 (26) . Thus there exists a population of cells with no "unstable" aberrations, and within this population the reciprocal translocations have a Poisson distribution, with a mean yield equal to that of the entire population. Hence, if it is assumed that every "unstable" aberration is cell-lethal, the surviving fraction will still have a reciprocal translocation yield equal to the original yield. Cellular radioresistance to both killing and translocation production, and reduced proliferative capacity of translocation-bearing cells, could conceivably reduce the ultimate yield of recovered translocations, but we do not think they can account for a fourfold difference.
There are two other mechanisms that can dramatically reduce the initial yield of reciprocal translocations. For the sake of simplicity let us consider only that class of cells with no "unstable" aberrations and a normal proliferative capacity. Reciprocal translocations will be distributed between these cells so that the numbers of cells with 0, 1, 2, . . ., etc. will be the terms of a Poisson for the induced mean yield. It has been shown that approximately 10-20% of all translocations are incomplete (27) , i.e., an acentric fragment is generated by failure of one or more of the chromosome products to rejoin completely. Since loss of large pieces of genetic material is generally celllethal (28, 29) , it is expected that this 10-207%o of incomplete translocations will be lost through cell death. Since the zero class will not be affected, this will result in a 10-20%o reduction in the mean yield. Second, all stages of the cell cycle exist in the spermatogonial germ cells, and consequently chromatid-type aberrations will be formed. Chromatid reciprocal translocations will involve only two of the four chromatid strands, and if random segregation occurs at the next mitotic division four classes of daughter cells are expected to be formed in equal frequency (Fig. 3) . Of these four classes one will be normal, one will be a balanced translocation heterozygote, and two will be duplication deficien- cies. Cells in the latter two classes will die; consequently, for every chromatid reciprocal translocation that is formed only 0.25 are expected to be recovered. If a cell has two chromatid reciprocal translocations in it, the probability of recovering both of them in a daughter cell will be 1:16, and the probability of recovering at least one will be 1:8. It would appear that the low yield of reciprocal translocations observed in primary spermatocytes as opposed to the theoretical yield produced by equal doses in somatic cells can readily be explained by simple cell and chromosome kinetics. The question then arises as to whether these simple explanations can account for some of the apparently inexplicable results obtained with chemical mutagens.
Several papers have reported a complete lack of reciprocal translocations in primary spermatocytes after treatment of spermatogonia *with known chemical mutagens (30) (31) (32) . These observations are highly unusual in light of the fact that the same chemicals have been shown to produce dominant lethals and reciprocal translocations when postmeiotic cells are treated (33) (34) (35) (36) , and they are also known to produce chromosome aberrations in the bone marrow and in spermatogonia. Since the aberrations are produced in the spermatogonia, the obvious question is why they are never recovered in the primary spermatocytes. In addition, we also must ask, "How meaningful are tests for chromosome aberration production in bone marrow and spermatogonia by chemicals if the damage is never realized in subsequent generations?"
Most of the chemicals tested to this point are very specific in their time and mode of action (37) The proportion of cells with the same number of asymmetrical exchanges would be the same, and the relative frequencies of the various combinations would be as shown in Table 3 . We have assumed that all asymmetrical exchanges are lethal; thus, any cell containing one will never propagate, and we must contend only with those having only symmetrical exchanges. Thus, if we take a theoretical population of 1,000 scored cells, approximately 50% of which were in S at the time of the MMS treatment and sustained chromosome damage at the level of 120 % chromatid interchanges, only 3.4% symmetrical exchanges would be expected to be seen in the subsequent primary spermatocytes.
This figure is derived in the following way. Half, or 500, of the 1000 cells would have been unlabeled and practically void of Thus the original yield of 60% chromatid exchanges observed in treated spermatogonia is expected to yield only 3.4%o reciprocal translocations in the primary spermatocytes. The yield of 3.4%o estimated in this example will, of course, vary if the values for labeling index or the proportion of incompleteness differ from those used here. These calculations do not take into account possible selective disadvantages caused by the translocation once it survives the first mitotic division. These could conceivably reduce the recovered yield even more. It is reasonably obvious from these calculations that restraint should be used in estimating genetic hazards from chromatid aberration yields in bone marrow and spermatogonia.
We hasten to add that our considerations are theoretical in nature, and that they should be tested by an experiment designed to enable the parameters used in the foregoing example to be determined. In this way, the proportion of reciprocal translocations expected to be found in primary spermatocytes from a known yield observed in spermatogonia could be compared with the actual number observed in spermatocytes after treatment of spermatogonia. The aberrations should be classified so that the frequencies of symmetrical and asymmetrical interchanges would be known; the proportion of incomplete interchanges should also be recorded; and the labeling indexes as well as the frequencies of aberrations in labeled and unlabeled cells should also be obtained. Such information would enable us to offer some explanation for the observation that certain chemicals induce chromatid aberrations in spermatogonial cells but none are recovered in primary spermatocytes, and it should also provide a basis for evaluating the possible genetic hazard from chemicals.
